Analysis of associations between biomarkers and tumor grading revealed statistically significant differences in promoter hypermethylation of RASSF1, ADAMTS12 (G1 vs. G2), and MT1E (G2 vs. G3) (p < 0.05; Figure 1E). This evidence concerns the gene RASSF1 and neoplasm.